Neuropathologie et physiopathologie de la maladie de Parkinson : focus sur l’α-synucléine
- 1 March 2017
- journal article
- Published by Elsevier in La Presse Médicale
- Vol. 46 (2) , 182-186
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteriaThe Lancet Neurology, 2009
- Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body DiseaseJournal of Biological Chemistry, 2006
- Lewy bodiesProceedings of the National Academy of Sciences, 2006
- Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophyActa Neuropathologica, 1998
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- α-Synuclein in Lewy bodiesNature, 1997
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminalThe Journal of Neuroscience, 1988
- Lewy bodies are ubiquitinatedActa Neuropathologica, 1988